The deal builds on Novonesis’ original 2013 investment in MicroBioGen and its current 23% stake in the Sydney-based firm, extending a collaboration between the two companies that spans more than a decade.
The new range is derived from natural sources and is intended for use across categories such as beverages, confectionery, dairy products, desserts, bakery items, and plant-based foods.
The new president brings nearly 20 years of global leadership experience and plans to strengthen Cimbria’s position across Europe, North America and other agricultural markets.
The company’s latest innovation, a fermented gluten-free bread binder, aims to provide manufacturers with a clean-label solution that enhances both functionality and consumer appeal.
New system focuses on high capacity, cleaner operation, and easier maintenance.